Treatment pathway of bone sarcoma in children, adolescents, and young adults
about
Long noncoding RNA LeXis promotes osteosarcoma growth through upregulation of CTNNB1 expression.Long noncoding RNA NBAT1 negatively modulates growth and metastasis of osteosarcoma cells through suppression of miR-21.Extent of physician-pharmaceutical industry interactions in low- and middle-income countries: a systematic review.Pediatric soft tissue sarcoma of the limbs: clinical outcome of 97 patients.A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas
P2860
Treatment pathway of bone sarcoma in children, adolescents, and young adults
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Treatment pathway of bone sarcoma in children, adolescents, and young adults
@ast
Treatment pathway of bone sarcoma in children, adolescents, and young adults
@en
type
label
Treatment pathway of bone sarcoma in children, adolescents, and young adults
@ast
Treatment pathway of bone sarcoma in children, adolescents, and young adults
@en
prefLabel
Treatment pathway of bone sarcoma in children, adolescents, and young adults
@ast
Treatment pathway of bone sarcoma in children, adolescents, and young adults
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Treatment pathway of bone sarcoma in children, adolescents, and young adults
@en
P2093
David M Loeb
Diana A Steppan
Eric T Shinohara
Julia A Bridge
Lars Wagner
Masanori Hayashi
Michael S Isakoff
Odion Binitie
P2860
P304
P356
10.1002/CNCR.30589
P407
P5008
P577
2017-03-21T00:00:00Z
2017-06-15T00:00:00Z